ESC25: GE HealthCare Showcases AI Cardiology Innovations for Earlier and More Accurate Diagnoses
At ESC 2025, GE HealthCare introduced several AI-powered solutions designed to streamline cardiology workflows and enhance early, accurate diagnosis of cardiovascular disease23.
ViewPoint EchoPilot™ automates echocardiography measurements and reporting, reducing manual inputs by up to 80% and minimizing diagnostic variability12.
CardIQ Suite™ uses an automated calcium scoring algorithm to detect coronary artery disease in seconds, yielding faster and more consistent diagnoses1.
The Revolution™ Vibe CT system enables unlimited one-beat cardiac imaging, cutting scan times by 50% and delivering high-quality coronary CT angiography in a single heartbeat13.
GE HealthCare partners with Volta Medical, integrating AI for real-time assessments in complex electrophysiology procedures via the ComboLab™ AltiX AI.i platform1.
Their cardiology AI technologies span the full care pathway:
screening, diagnosis, intervention, and follow-up—targeting improved outcomes for patients at every stage2.
GE HealthCare holds over 100 FDA authorizations for AI-enabled cardiology devices, showing strong regulatory leadership and clinical validation1.
The company is well-positioned for a cardiology AI market projected to reach $36.64 billion by 2034, growing at a CAGR of 34.38%1.
Sources:
1. https://www.ainvest.com/news/ge-healthcare-ai-driven-cardiology-innovations-strategic-play-19-7b-market-2508/
2. https://www.dicardiology.com/content/ge-healthcare-highlight-integrated-cardiology-care-solutions-and-ai-driven-innovations-esc